4//SEC Filing
THOMPSON PHILLANDAS T. 4
Accession 0001140361-18-030196
CIK 0001012477other
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 6:58 PM ET
Size
12.8 KB
Accession
0001140361-18-030196
Insider Transaction Report
Form 4
THOMPSON PHILLANDAS T.
See Remarks
Transactions
- Purchase
ADSs
2018-06-26$5.77/sh+10,000$57,700→ 91,000 total
Holdings
- 100,000
Stock Option (right to buy)
Exercise: $10.40Exp: 2026-12-14→ ADSs (100,000 underlying) - 100,000
Stock Option (right to buy)
Exercise: $7.36Exp: 2023-12-12→ ADSs (100,000 underlying) - 95,000
Stock Option (right to buy)
Exercise: $16.30Exp: 2024-12-11→ ADSs (95,000 underlying) - 100,000
Stock Option (right to buy)
Exercise: $14.35Exp: 2025-12-10→ ADSs (100,000 underlying) - 80,000
Stock Option (right to buy)
Exercise: $8.95Exp: 2027-12-12→ ADSs (80,000 underlying)
Footnotes (7)
- [F1]The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
- [F2]Includes (a) 10,000 restricted ADSs granted under the issuer's "Free Share" award program on 12/11/2014, all of which will be issued to the reporting person on the 4th anniversary of the grant date; (b) 20,000 restricted ADSs granted under the "Free Share" award program on 8/10/2016, all of which will be issued to the reporting person on the 2nd anniversary of the grant date; (c) 18,000 restricted ADSs granted under the "Free Share" award program on 12/14/2016, all of which will be issued to the reporting person on the 2nd anniversary of the grant date; and (d) 18,000 restricted ADSs granted under the issuer's Omnibus Incentive Compensation Plan on 12/12/2017, of which 12,000 and 6,000 ADSs will vest and be issued to the reporting person on the 2nd anniversary and 3rd anniversary, respectively, of the grant date (with such vesting subject to the reporting person remaining in continuous service until the applicable anniversary).
- [F3]Options become exercisable as to 25,000 ADSs on each of the first four anniversaries after the 12/12/2013 grant date.
- [F4]Options become exercisable as to 23,750 ADSs on each of the first four anniversaries after the 12/11/2014 grant date.
- [F5]Options become exercisable as to 25,000 ADSs on each of the first four anniversaries after the 12/10/2015 grant date.
- [F6]Options become exercisable as to 25,000 ADSs on each of the first four anniversaries after the 12/14/2016 grant date.
- [F7]Options become exercisable as to 20,000 ADSs on each of the first four anniversaries after the 12/12/2017 grant date.
Documents
Issuer
AVADEL PHARMACEUTICALS PLC
CIK 0001012477
Entity typeother
Related Parties
1- filerCIK 0001661781
Filing Metadata
- Form type
- 4
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 6:58 PM ET
- Size
- 12.8 KB